SK282440B6 - Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje - Google Patents

Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje Download PDF

Info

Publication number
SK282440B6
SK282440B6 SK213-97A SK21397A SK282440B6 SK 282440 B6 SK282440 B6 SK 282440B6 SK 21397 A SK21397 A SK 21397A SK 282440 B6 SK282440 B6 SK 282440B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
medicament
manufacture
treatment
Prior art date
Application number
SK213-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK21397A3 (en
Inventor
Jan-Robert Schwark
Joachim Brendel
Heinz-Werner Kleemann
Hans Jochen Lang
Andreas Weichert
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SK21397A3 publication Critical patent/SK21397A3/sk
Publication of SK282440B6 publication Critical patent/SK282440B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK213-97A 1996-02-15 1997-02-13 Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje SK282440B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (2)

Publication Number Publication Date
SK21397A3 SK21397A3 (en) 1997-09-10
SK282440B6 true SK282440B6 (sk) 2002-02-05

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
SK213-97A SK282440B6 (sk) 1996-02-15 1997-02-13 Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje

Country Status (29)

Country Link
US (1) US5756535A (ru)
EP (1) EP0790245B1 (ru)
JP (1) JP4402747B2 (ru)
KR (1) KR970061887A (ru)
AR (1) AR005812A1 (ru)
AT (1) ATE202096T1 (ru)
AU (1) AU706554B2 (ru)
BR (1) BR9700990A (ru)
CA (1) CA2197628C (ru)
CZ (1) CZ45597A3 (ru)
DE (2) DE19605610A1 (ru)
DK (1) DK0790245T3 (ru)
ES (1) ES2158383T3 (ru)
GR (1) GR3036122T3 (ru)
HR (1) HRP970081B1 (ru)
HU (1) HUP9700437A3 (ru)
ID (1) ID15889A (ru)
IL (1) IL120214A (ru)
MX (1) MX9701163A (ru)
NO (1) NO315424B1 (ru)
NZ (1) NZ314230A (ru)
PL (1) PL318412A1 (ru)
PT (1) PT790245E (ru)
RU (1) RU2193033C2 (ru)
SI (1) SI0790245T1 (ru)
SK (1) SK282440B6 (ru)
TR (1) TR199700109A2 (ru)
TW (1) TW445261B (ru)
ZA (1) ZA971260B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
WO2000064445A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
RO122203B1 (ro) 2001-10-19 2009-02-27 Toyama Chemical Co., Ltd. Derivaţi de alchil eter şi sărurile acestora

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
IL120214A (en) 2000-08-31
SK21397A3 (en) 1997-09-10
PT790245E (pt) 2001-10-30
US5756535A (en) 1998-05-26
CA2197628A1 (en) 1997-08-16
EP0790245A1 (de) 1997-08-20
CZ45597A3 (en) 1997-09-17
KR970061887A (ko) 1997-09-12
GR3036122T3 (en) 2001-09-28
TW445261B (en) 2001-07-11
HRP970081A2 (en) 1998-04-30
ATE202096T1 (de) 2001-06-15
HU9700437D0 (en) 1997-04-28
IL120214A0 (en) 1997-06-10
JP4402747B2 (ja) 2010-01-20
DE59703746D1 (de) 2001-07-19
AU1265997A (en) 1997-08-21
ID15889A (id) 1997-08-14
EP0790245B1 (de) 2001-06-13
PL318412A1 (en) 1997-08-18
JPH09249660A (ja) 1997-09-22
BR9700990A (pt) 1998-09-01
NO970697D0 (no) 1997-02-14
ZA971260B (en) 1997-08-15
HUP9700437A2 (hu) 1998-08-28
RU2193033C2 (ru) 2002-11-20
HRP970081B1 (en) 2003-04-30
AU706554B2 (en) 1999-06-17
ES2158383T3 (es) 2001-09-01
HUP9700437A3 (en) 2000-03-28
SI0790245T1 (en) 2001-08-31
NO970697L (no) 1997-08-18
TR199700109A2 (tr) 1997-09-21
DK0790245T3 (da) 2001-09-03
AR005812A1 (es) 1999-07-14
MX9701163A (es) 1997-08-30
NZ314230A (en) 1997-12-19
DE19605610A1 (de) 1997-08-21
NO315424B1 (no) 2003-09-01
CA2197628C (en) 2006-05-16

Similar Documents

Publication Publication Date Title
FI120341B (fi) Menetelmä terapeuttisesti käyttökelpoisen bentsoyyliguanidiinin valmistamiseksi
SK3542003A3 (en) Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
JP3718240B2 (ja) 置換ベンゾイルグアニジン、その製造方法およびそれを含有する医薬
CZ287263B6 (en) Guanidides of phenyl substituted alkenylcarboxylic acid carrying perfluoroalkyl groups, process of their preparation, their use as medicaments or diagnostic agents as well as medicament containing thereof
JPH08319266A (ja) フルオロフェニル置換アルケニルカルボン酸グアニジド、その製造方法、医薬または診断薬としてのその使用およびそれらを含有する医薬
US5883133A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them
CZ289760B6 (cs) Benzoylguanidinové deriváty, způsob jejich přípravy, jejich pouľití jako léčivo nebo diagnostické činidlo a léčivo tyto deriváty obsahující
US6632840B1 (en) Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
JP3647901B2 (ja) 尿素置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
SK62996A3 (en) Substituted benzyloxycarbonyl guanidines, method of their producing, their use and drugs containing them
JPH06234727A (ja) 置換されたベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
CZ291188B6 (cs) Benzoylguanidiny, způsob jejich přípravy, jejich pouľití a léčiva tyto benzoylguanidiny obsahující
US5665739A (en) Substituted benzoylguanidines, process and their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
SK282440B6 (sk) Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje
SK282628B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich výroby, ich použitie ako liečiv alebo diagnostík, ako aj liečivo, ktoré ich obsahuje
SK281604B6 (sk) 4-fluóralkylsubstituované benzoylguanidíny, spôsob ich výroby, ich použitie na výrobu liečiva alebo diagnostika a liečivo, ktoré ich obsahuje
RU2159762C2 (ru) Замещенные бензоилгуанидины, способ их получения, способ ингибирования и фармацевтический препарат
SK282356B6 (sk) Substituované 1-naftoylguanidíny, spôsob ich výroby, ich použitie ako liečiva alebo diagnostického prostriedku a liečivo, ktoré ich obsahuje
JPH08225514A (ja) 置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
SK146596A3 (en) Sulfonylaminosubstituted benzoylguanidines, producing method, their use as a drug or diagnostic agent, as well as a drug containing the same
MXPA97001163A (en) Guidelines of substitute thiophenyl alcoholic substitute acids, procedure for its preparation, its employment as a medicine or diagnostic agent, as well as a medication that contains them
SK282351B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich výroby, ich použitie ako liečiva alebo diagnostického prostriedku a liečivo, ktoré ich obsahuje
SK281753B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich výroby, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje
SK283934B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiva a liečivá, ktoré ich obsahujú